Access cutting-edge allergic conjunctivitis treatment through this phase 3 clinical trial at a research site in Andover. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Andover location
Preparing your pre-screening questions…
Access allergic conjunctivitis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related allergic conjunctivitis treatment provided free
Check if you qualify for this allergic conjunctivitis clinical trial in Andover, MA
No-Cost Study Care
Local to Andover
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching two experimental medicines, freneslerbart and mevonlerbart. Freneslerbart and mevonlerbart can be given alone or together. When given together, the medicine is called "REGN-2Cat". These medicines are also known as the "study drugs". The aim of the study is to see what side effects freneslerbart, mevonlerbart, and REGN-2Cat may have and if they help reduce eye allergy symptoms caused by cat hair/dander compared with a placebo. The study is looking at several other research questions, including: * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects) * How long the study drug effect lasts
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07675811) has an active research site in Andover, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for allergic conjunctivitis treatment options in Andover, MA, this clinical trial (NCT07675811) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Andover research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced allergic conjunctivitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all allergic conjunctivitis clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Andover — not just this study.
Browse Leukemia Trials in Andover →